Treatment of Alpha-1-antitrypsin deficiency in Necrotizing Panniculitis

Necrotizing panniculitis is an extremely rare and serious cutaneous complication of Alpha-1-antitrypsin deficiency (AATD). Recognising this presentation is critical — it requires a specific therapeutic approach distinct from the more commonly encountered pulmonary and hepatic manifestations of AATD.

Clinical scenario

Panniculitis associated with AATD presents with characteristic skin findings:

Nodular, painful, erythematous (red) skin lesions
Frequently accompanied by an oily discharge
Tendency to involve areas of prior trauma — thighs, buttocks, abdomen, and upper limbs

This is an extremely rare disease manifestation that warrants prompt recognition and targeted management.

Treatment approach

The structured regimen for this scenario centres on a specific replacement-based strategy targeting the underlying deficiency — the complete protocol, including sequencing and clinical decision points, is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

Panniculitis associated with AATD is an extremely rare disease, and its clinical manifestations include nodular, painful, red skin lesions, often with an oily discharge, affecting areas of previous trauma such as the thighs, buttocks, abdomen, and upper limbs.

Treatment with AAT replacement has shown excellent results, with rapid clinical responses, and should be used in cases refractory to other therapies.

View source ↗